30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Pharmacyclics Inc (PCYC)

Track

Stock chart
Ticker: PCYC Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Soni Manmeet Singh
Chief Financial Officer
2 sales — total 870,756 USD
Sale 13 Mar 2015
Value US$1,945,474.86 | Price 317.37 | Shares 43,318
Sale 13 Mar 2015
Value US$4,969,247.45 | Price 331.23 | Shares 12,782
Sale 12 Mar 2015
Value US$585,303.80 | Price 130.20 | Shares 12,219
Sale 11 Mar 2015
Value US$6,124,506.70 | Price 254.15 | Shares 24,098
Sale 11 Mar 2015
Value US$7,623,444.00 | Price 254.11 | Shares 30,000
Sale 13 Nov 2014
Value US$423,901.80 | Price 141.30 | Shares 3,000
Sale 13 Nov 2014
Value US$141,442.00 | Price 141.44 | Shares 1,000
Sale 12 Nov 2014
Value US$90,475.00 | Price 137.50 | Shares 658
Sale 12 Nov 2014
Value US$727,740.97 | Price 138.01 | Shares 5,273
Sale 10 Nov 2014
Value US$866,997.17 | Price 133.88 | Shares 6,476
Sale 10 Nov 2014
Value US$668,808.00 | Price 133.76 | Shares 5,000
Sale 10 Nov 2014
Value US$1,141,721.61 | Price 133.94 | Shares 8,524
Sale 10 Nov 2014
Value US$400,500.00 | Price 133.50 | Shares 3,000
Sale 10 Nov 2014
Value US$200,805.00 | Price 133.87 | Shares 1,500
Sale 7 Nov 2014
Value US$209,400.51 | Price 135.01 | Shares 1,551
Sale 7 Nov 2014
Value US$672,500.00 | Price 134.50 | Shares 5,000
Sale 4 Sep 2014
Value US$610,000.00 | Price 122.00 | Shares 5,000
Sale 3 Sep 2014
Value US$605,500.00 | Price 121.10 | Shares 5,000
Sale 3 Sep 2014
Value US$245,480.00 | Price 122.74 | Shares 2,000
Sale 27 Aug 2014
Value US$186,000.00 | Price 124.00 | Shares 1,500
Sale 13 Aug 2014
Value US$484,040.00 | Price 121.01 | Shares 4,000
Sale 13 Aug 2014
Value US$1,235,808.00 | Price 123.58 | Shares 10,000
Sale 7 Aug 2014
Value US$4,118,610.14 | Price 120.92 | Shares 34,062
Sale 5 Mar 2014
Value US$421,503.60 | Price 140.50 | Shares 3,000
Sale 5 Mar 2014
Value US$916,599.08 | Price 139.66 | Shares 6,563
Sale 5 Mar 2014
Value US$880,115.38 | Price 140.75 | Shares 6,253
Sale 5 Mar 2014
Value US$2,100,033.00 | Price 140.00 | Shares 15,000
Sale 4 Mar 2014
Value US$480,281.76 | Price 138.33 | Shares 3,472
Sale 4 Mar 2014
Value US$1,884,330.16 | Price 137.07 | Shares 13,747
Sale 4 Mar 2014
Value US$2,414,483.75 | Price 137.97 | Shares 17,500
Sale 27 Feb 2014
Value US$3,622,990.00 | Price 144.92 | Shares 25,000
Sale 26 Feb 2014
Value US$3,778,170.00 | Price 147.13 | Shares 25,680
Sale 25 Feb 2014
Value US$4,158,496.32 | Price 147.70 | Shares 28,155
Sale 19 Dec 2013
Value US$201,552.60 | Price 100.78 | Shares 2,000
Sale 19 Dec 2013
Value US$302,799.00 | Price 100.93 | Shares 3,000
Sale 18 Dec 2013
Value US$990,380.00 | Price 99.04 | Shares 10,000
Sale 17 Dec 2013
Value US$1,020,000.00 | Price 102.00 | Shares 10,000
Sale 16 Dec 2013
Value US$2,151,000.00 | Price 107.55 | Shares 20,000
Sale 16 Dec 2013
Value US$2,459,681.16 | Price 107.72 | Shares 22,835
Sale 13 Dec 2013
Value US$3,360,113.69 | Price 107.82 | Shares 31,165
Sale 6 Jun 2013
Value US$1,596,993.75 | Price 85.17 | Shares 18,750
Sale 31 May 2013
Value US$712,000.00 | Price 89.00 | Shares 8,000
Sale 31 May 2013
Value US$4,598,115.00 | Price 91.96 | Shares 50,000
Sale 31 May 2013
Value US$1,319,510.36 | Price 91.13 | Shares 14,479
Sale 31 May 2013
Value US$480,960.84 | Price 91.84 | Shares 5,237
Planned sale 11 Feb 2013
Value US$839,666.40 | Price 69.97 | Shares 12,000
Planned sale 5 Feb 2013
Value US$1,411,510.00 | Price 70.58 | Shares 20,000
Sale 17 Jan 2013
Value US$39,229.49 | Price 67.29 | Shares 583
Sale 11 Jan 2013
Value US$335,550.00 | Price 67.11 | Shares 5,000
Sale 9 Jan 2013
Value US$698,205.30 | Price 66.30 | Shares 10,531
Sale 8 Jan 2013
Value US$162,500.00 | Price 65.00 | Shares 2,500
Sale 8 Jan 2013
Value US$647,000.00 | Price 64.70 | Shares 10,000
Sale 7 Jan 2013
Value US$224,700.00 | Price 64.20 | Shares 3,500
Sale 31 Dec 2012
Value US$419,475.53 | Price 58.50 | Shares 7,171
Sale 28 Dec 2012
Value US$1,064,124.54 | Price 57.98 | Shares 18,354
Sale 27 Dec 2012
Value US$692,239.01 | Price 58.02 | Shares 11,931
Sale 27 Dec 2012
Value US$157,500.00 | Price 60.00 | Shares 2,625
Sale 27 Dec 2012
Value US$606,225.00 | Price 59.00 | Shares 10,275
Sale 26 Dec 2012
Value US$5,900.00 | Price 59.00 | Shares 100
Sale 20 Dec 2012
Value US$2,412,274.24 | Price 61.12 | Shares 39,469
Sale 18 Dec 2012
Value US$1,123,380.00 | Price 62.41 | Shares 18,000
Sale 18 Dec 2012
Value US$2,597,711.62 | Price 62.51 | Shares 41,558
Sale 17 Dec 2012
Value US$2,160,698.20 | Price 62.73 | Shares 34,442
Sale 17 Dec 2012
Value US$3,106,840.00 | Price 62.14 | Shares 50,000
Planned sale 17 May 2012
Value US$29,190.00 | Price 30.00 | Shares 973
Planned sale 17 May 2012
Value US$33,780.00 | Price 30.00 | Shares 1,126
Planned sale 17 May 2012
Value US$36,120.00 | Price 30.00 | Shares 1,204
Planned sale 17 May 2012
Value US$3,720.00 | Price 30.00 | Shares 124
Planned sale 17 May 2012
Value US$65,550.00 | Price 30.00 | Shares 2,185
Planned sale 17 May 2012
Value US$225,000.00 | Price 30.00 | Shares 7,500
Planned sale 17 May 2012
Value US$52,620.00 | Price 30.00 | Shares 1,754
Planned sale 17 May 2012
Value US$53,310.00 | Price 30.00 | Shares 1,777
Planned sale 17 May 2012
Value US$57,660.00 | Price 30.00 | Shares 1,922
Planned sale 13 Feb 2012
Value US$48,375.00 | Price 25.00 | Shares 1,935
Planned sale 13 Feb 2012
Value US$93,750.00 | Price 25.00 | Shares 3,750
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2015-03-13 2015-03-13 S Sale Soni Manmeet Singh

Chief Financial Officer

Officer
43,318 +4.1%
317.37
US$1,945,475 		43,318 +4.1% 317.37 US$1,945,475
2015-03-13 2015-03-13 S Sale Soni Manmeet Singh

Chief Financial Officer

Officer
12,782 -32.3%
331.23
US$4,969,247 		12,782 -32.3% 331.23 US$4,969,247
2015-03-12 2015-03-12 S Sale Tan Heow

Chief Quality&Tech Operations

Officer
12,219 -16.1%
130.20
US$585,304 		12,219 -16.1% 130.20 US$585,304
2015-03-13 2015-03-11 S Sale Soni Manmeet Singh

Chief Financial Officer

Officer
24,098 -29.3%
254.15
US$6,124,507 		24,098 -29.3% 254.15 US$6,124,507
2015-03-13 2015-03-11 S Sale Zanganeh Maky

Chief Operating Officer

Officer
30,000 -11.8%
254.11
US$7,623,444 		30,000 -11.8% 254.11 US$7,623,444
2014-11-17 2014-11-13 S Sale Fardis Maria

Chief of Oncology Ops & Allian

Officer
3,000 -48.4%
141.30
US$423,902 		3,000 -48.4% 141.30 US$423,902
2014-11-17 2014-11-13 S Sale Soni Manmeet Singh

Chief Financial Officer

Officer
1,000 -2.5%
141.44
US$141,442 		1,000 -2.5% 141.44 US$141,442
2014-11-12 2014-11-12 S Sale Zanganeh Maky

Chief Operating Officer

Officer
658 -0.3%
137.50
US$90,475 		658 -0.3% 137.50 US$90,475
2014-11-12 2014-11-12 S Sale Zanganeh Maky

Chief Operating Officer

Officer
5,273 -2.4%
138.01
US$727,741 		5,273 -2.4% 138.01 US$727,741
2014-11-12 2014-11-10 S Sale Zanganeh Maky

Chief Operating Officer

Officer
6,476 -3.0%
133.88
US$866,997 		6,476 -3.0% 133.88 US$866,997
2014-11-12 2014-11-10 S Sale Zanganeh Maky

Chief Operating Officer

Officer
5,000 -2.3%
133.76
US$668,808 		5,000 -2.3% 133.76 US$668,808
2014-11-12 2014-11-10 S Sale Zanganeh Maky

Chief Operating Officer

Officer
8,524 -3.7%
133.94
US$1,141,722 		8,524 -3.7% 133.94 US$1,141,722
2014-11-12 2014-11-10 S Sale Zanganeh Maky

Chief Operating Officer

Officer
3,000 -1.3%
133.50
US$400,500 		3,000 -1.3% 133.50 US$400,500
2014-11-10 2014-11-10 S Sale Love Richard B

General Counsel

Officer
1,500 -88.0%
133.87
US$200,805 		1,500 -88.0% 133.87 US$200,805
2014-11-12 2014-11-07 S Sale Zanganeh Maky

Chief Operating Officer

Officer
1,551 -0.7%
135.01
US$209,401 		1,551 -0.7% 135.01 US$209,401
2014-11-10 2014-11-07 S Sale Fardis Maria

Chief of Oncology Ops & Allian

Officer
5,000 -61.0%
134.50
US$672,500 		5,000 -61.0% 134.50 US$672,500
2014-09-04 2014-09-04 S Sale Zanganeh Maky

Chief Operating Officer

Officer
5,000 -2.3%
122.00
US$610,000 		5,000 -2.3% 122.00 US$610,000
2014-09-04 2014-09-03 S Sale Zanganeh Maky

Chief Operating Officer

Officer
5,000 -2.3%
121.10
US$605,500 		5,000 -2.3% 121.10 US$605,500
2014-09-04 2014-09-03 S Sale Zanganeh Maky

Chief Operating Officer

Officer
2,000 -0.9%
122.74
US$245,480 		2,000 -0.9% 122.74 US$245,480
2014-08-28 2014-08-27 S Sale Love Richard B

General Counsel

Officer
1,500 -88.0%
124.00
US$186,000 		1,500 -88.0% 124.00 US$186,000
2014-08-15 2014-08-13 S Sale Fardis Maria

Chief of Oncology Ops & Allian

Officer
4,000 -55.6%
121.01
US$484,040 		4,000 -55.6% 121.01 US$484,040
2014-08-13 2014-08-13 S Sale Tan Heow

Chief Quality&Tech Operations

Officer
10,000 -84.2%
123.58
US$1,235,808 		10,000 -84.2% 123.58 US$1,235,808
2014-08-07 2014-08-07 S Sale McGreivy Jesse

Chief Medical Officer

Officer
34,062 -100.0%
120.92
US$4,118,610 		34,062 -100.0% 120.92 US$4,118,610
2014-03-07 2014-03-05 S Sale Fardis Maria

Chief of Oncology Ops & Allian

Officer
3,000 -50.1%
140.50
US$421,504 		3,000 -50.1% 140.50 US$421,504
2014-03-06 2014-03-05 S Sale McGreivy Jesse

Chief Medical Officer

Officer
6,563 -100.0%
139.66
US$916,599 		6,563 -100.0% 139.66 US$916,599
2014-03-06 2014-03-05 S Sale Sjovall Boultbee Paula S

EVP, Sales and Marketing

Officer
6,253 -78.2%
140.75
US$880,115 		6,253 -78.2% 140.75 US$880,115
2014-03-06 2014-03-05 S Sale Hemmi Gregory

Sr. VP Chemical Operations

Officer
15,000 -28.3%
140.00
US$2,100,033 		15,000 -28.3% 140.00 US$2,100,033
2014-03-06 2014-03-04 S Sale HALVORSON ERIC H Non-Executive Director
3,472 -77.6%
138.33
US$480,282 		3,472 -77.6% 138.33 US$480,282
2014-03-06 2014-03-04 S Sale Sjovall Boultbee Paula S

EVP, Sales and Marketing

Officer
13,747 -88.8%
137.07
US$1,884,330 		13,747 -88.8% 137.07 US$1,884,330
2014-03-05 2014-03-04 S Sale Chang Betty Y

VP, Research/Biology

Officer
17,500 -82.3%
137.97
US$2,414,484 		17,500 -82.3% 137.97 US$2,414,484
2014-02-28 2014-02-27 S Sale van den Broek Richard Non-Executive Director
25,000 -45.8%
144.92
US$3,622,990 		25,000 -45.8% 144.92 US$3,622,990
2014-02-28 2014-02-26 S Sale van den Broek Richard Non-Executive Director
25,680 -32.0%
147.13
US$3,778,170 		25,680 -32.0% 147.13 US$3,778,170
2014-02-28 2014-02-25 S Sale van den Broek Richard Non-Executive Director
28,155 -26.0%
147.70
US$4,158,496 		28,155 -26.0% 147.70 US$4,158,496
2013-12-20 2013-12-19 S Sale Tan Heow

Chief Quality&Tech Operations

Officer
2,000 -92.2%
100.78
US$201,553 		2,000 -92.2% 100.78 US$201,553
2013-12-20 2013-12-19 S Sale Tan Heow

Chief Quality&Tech Operations

Officer
3,000 -58.0%
100.93
US$302,799 		3,000 -58.0% 100.93 US$302,799
2013-12-18 2013-12-18 S Sale Hemmi Gregory

VP Chemical Operations

Officer
10,000 -28.6%
99.04
US$990,380 		10,000 -28.6% 99.04 US$990,380
2013-12-18 2013-12-17 S Sale Hemmi Gregory

VP Chemical Operations

Officer
10,000 -28.6%
102.00
US$1,020,000 		10,000 -28.6% 102.00 US$1,020,000
2013-12-18 2013-12-16 S Sale Zanganeh Maky

Chief Operating Officer

Officer
20,000 -8.7%
107.55
US$2,151,000 		20,000 -8.7% 107.55 US$2,151,000
2013-12-16 2013-12-16 S Sale Erdtmann Rainer M

Sr. VP, IR and Admin

Officer
22,835 -66.5%
107.72
US$2,459,681 		22,835 -66.5% 107.72 US$2,459,681
2013-12-16 2013-12-13 S Sale Erdtmann Rainer M

Sr. VP, IR and Admin

Officer
31,165 -73.1%
107.82
US$3,360,114 		31,165 -73.1% 107.82 US$3,360,114
2013-06-06 2013-06-06 S Sale Shearer Scott T

VP, Global Quality

Officer
18,750 -100.0%
85.17
US$1,596,994 		18,750 -100.0% 85.17 US$1,596,994
2013-05-31 2013-05-31 S Sale Love Richard B

VP and General Counsel

Officer
8,000 -100.0%
89.00
US$712,000 		8,000 -100.0% 89.00 US$712,000
2013-05-31 2013-05-31 S Sale Hemmi Gregory

VP Chemical Operations

Officer
50,000 -67.4%
91.96
US$4,598,115 		50,000 -67.4% 91.96 US$4,598,115
2013-05-31 2013-05-31 S Sale McGreivy Jesse

VP, Clinical Science

Officer
14,479 -100.0%
91.13
US$1,319,510 		14,479 -100.0% 91.13 US$1,319,510
2013-05-31 2013-05-31 S Sale Tan Heow

Chief of Technical Operations

Officer
5,237 -100.0%
91.84
US$480,961 		5,237 -100.0% 91.84 US$480,961
2013-02-11 2013-02-11 PlS Planned sale Buggy Joseph J

VP, Research

Officer
12,000 -64.2%
69.97
US$839,666 		12,000 -64.2% 69.97 US$839,666
2013-02-05 2013-02-05 PlS Planned sale Loury David J

Chief Scientific Officer

Officer
20,000 -98.4%
70.58
US$1,411,510 		20,000 -98.4% 70.58 US$1,411,510
2013-01-18 2013-01-17 S Sale McGreivy Jesse

VP, Clinical Science

Officer
583 -100.0%
67.29
US$39,229 		583 -100.0% 67.29 US$39,229
2013-01-11 2013-01-11 S Sale Hemmi Gregory

VP Chemical Operations

Officer
5,000 -17.9%
67.11
US$335,550 		5,000 -17.9% 67.11 US$335,550
2013-01-10 2013-01-09 S Sale Loury David J

Chief Scientific Officer

Officer
10,531 -97.0%
66.30
US$698,205 		10,531 -97.0% 66.30 US$698,205
2013-01-09 2013-01-08 S Sale Fardis Maria

EVP, Operations and Alliances

Officer
2,500 -71.9%
65.00
US$162,500 		2,500 -71.9% 65.00 US$162,500
2013-01-08 2013-01-08 S Sale Loury David J

Chief Scientific Officer

Officer
10,000 -96.9%
64.70
US$647,000 		10,000 -96.9% 64.70 US$647,000
2013-01-07 2013-01-07 S Sale Fardis Maria

EVP, Operations and Alliances

Officer
3,500 -50.2%
64.20
US$224,700 		3,500 -50.2% 64.20 US$224,700
2013-01-02 2012-12-31 S Sale van den Broek Richard Non-Executive Director
7,171 -6.2%
58.50
US$419,476 		7,171 -6.2% 58.50 US$419,476
2012-12-28 2012-12-28 S Sale van den Broek Richard Non-Executive Director
18,354 -14.5%
57.98
US$1,064,125 		18,354 -14.5% 57.98 US$1,064,125
2012-12-28 2012-12-27 S Sale van den Broek Richard Non-Executive Director
11,931 -8.6%
58.02
US$692,239 		11,931 -8.6% 58.02 US$692,239
2012-12-27 2012-12-27 S Sale Hemmi Gregory

VP Chemical Operations

Officer
2,625 -10.2%
60.00
US$157,500 		2,625 -10.2% 60.00 US$157,500
2012-12-27 2012-12-27 S Sale Hemmi Gregory

VP Chemical Operations

Officer
10,275 -28.6%
59.00
US$606,225 		10,275 -28.6% 59.00 US$606,225
2012-12-27 2012-12-26 S Sale Hemmi Gregory

VP Chemical Operations

Officer
100 -0.4%
59.00
US$5,900 		100 -0.4% 59.00 US$5,900
2012-12-21 2012-12-20 S Sale Loury David J

Chief Scientific Officer

Officer
39,469 -99.2%
61.12
US$2,412,274 		39,469 -99.2% 61.12 US$2,412,274
2012-12-18 2012-12-18 S Sale Erdtmann Rainer M

VP, IR Education Training

Officer
18,000 -39.6%
62.41
US$1,123,380 		18,000 -39.6% 62.41 US$1,123,380
2012-12-18 2012-12-18 S Sale Erdtmann Rainer M

VP, IR Education Training

Officer
41,558 -47.7%
62.51
US$2,597,712 		41,558 -47.7% 62.51 US$2,597,712
2012-12-18 2012-12-17 S Sale Erdtmann Rainer M

VP, IR Education Training

Officer
34,442 -55.6%
62.73
US$2,160,698 		34,442 -55.6% 62.73 US$2,160,698
2012-12-17 2012-12-17 S Sale Buggy Joseph J

VP, Research

Officer
50,000 -88.2%
62.14
US$3,106,840 		50,000 -88.2% 62.14 US$3,106,840
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
973 -100.0%
30.00
US$29,190 		973 -100.0% 30.00 US$29,190
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
1,126 -100.0%
30.00
US$33,780 		1,126 -100.0% 30.00 US$33,780
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
1,204 -100.0%
30.00
US$36,120 		1,204 -100.0% 30.00 US$36,120
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
124 -100.0%
30.00
US$3,720 		124 -100.0% 30.00 US$3,720
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
2,185 -100.0%
30.00
US$65,550 		2,185 -100.0% 30.00 US$65,550
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
7,500 -100.0%
30.00
US$225,000 		7,500 -100.0% 30.00 US$225,000
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
1,754 -100.0%
30.00
US$52,620 		1,754 -100.0% 30.00 US$52,620
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
1,777 -100.0%
30.00
US$53,310 		1,777 -100.0% 30.00 US$53,310
2012-05-21 2012-05-17 PlS Planned sale Mehta Minesh Non-Executive Director
1,922 -100.0%
30.00
US$57,660 		1,922 -100.0% 30.00 US$57,660
2012-02-15 2012-02-13 PlS Planned sale Mehta Minesh Non-Executive Director
1,935 -100.0%
25.00
US$48,375 		1,935 -100.0% 25.00 US$48,375
2012-02-15 2012-02-13 PlS Planned sale Mehta Minesh Non-Executive Director
3,750 -100.0%
25.00
US$93,750 		3,750 -100.0% 25.00 US$93,750
Explore more

More insider trading research around Pharmacyclics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America